3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Breast Neoplasms
4
Oropharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Kidney Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Thyroid Nodule
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Salivary Gland Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Polycystic Ovary Syndrome
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Cervical Cancer
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Interventions
Platinum
3
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Radiotherapy
2
Radiation
2
cediranib
1
atezolizumab
1
Radiotherapy, Intensity-Modulated
1
Pharmacogenomic Testing
1
Combined Modality Therapy
1
Cerebral Decortication
1
Carboplatin
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Surveys and Questionnaires
×
30 days
×
Clear all
No trials found.